Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Franciska Erdő | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

full professor at Pázmány Péter Catholic University, Hungary

Franciska Vidáné Dr. Erdő is a distinguished researcher and professor in drug research and development, with extensive experience in academia and the pharmaceutical industry. Born on May 28, 1964, in Budapest, Hungary, she has contributed significantly to pharmacology, drug delivery, and biomedical research. Over her career, she has held leadership roles in prestigious institutions across Hungary, Germany, and France. As a full professor and lab head at Pázmány Péter Catholic University, she plays a key role in advancing scientific knowledge. Her research has been widely recognized, earning her multiple fellowships and memberships in international scientific societies. Dr. Erdő has supervised numerous students, organized international scientific meetings, and served as a reviewer for high-impact journals. She is also actively involved in grant evaluation for major research funding agencies in Europe, further establishing her as a leading expert in her field.

Professional Profile

Education

Dr. Erdő’s academic journey is rooted in pharmaceutical sciences. She obtained her MSc in Pharmacy from Semmelweis University, Faculty of Pharmacy, in 1987 with excellent distinction. She continued her studies at the same institution, earning her University Doctor title in pharmacology in 1994, followed by a PhD in 1997, both summa cum laude. To further enhance her expertise, she pursued a habilitation at Pázmány Péter Catholic University in 2019, ultimately achieving the title of full professor in 2024. Additionally, she has undertaken specialized training, including EU grant writing and experimental animal research under new EU regulations. Her diverse educational background has enabled her to excel in drug development, pharmacology, and biotechnology, equipping her with a strong foundation to lead innovative research in these fields.

Professional Experience

Dr. Erdő’s professional career spans more than three decades, encompassing roles in academia, research institutes, and the pharmaceutical industry. She has held various research fellow and senior research fellow positions in leading institutions such as Sanofi-Synthelabo Chinoin, IVAX Drug Research Institute, and SOLVO Biotechnology. Between 2000 and 2003, she was a Max Planck Fellow at the Max-Planck Institute in Germany, furthering her expertise in neurological research. She has also worked as a scientific researcher at Charité Medical University in Berlin. Since 2014, she has been an integral part of Pázmány Péter Catholic University, where she has progressed from senior research fellow to full professor and lab head. Her leadership in drug research and development, coupled with her extensive collaborations with international institutions, has significantly contributed to the advancement of pharmaceutical sciences.

Research Interests

Dr. Erdő’s research focuses on drug delivery across physiological barriers, including the skin, blood-brain barrier, and mucosal tissues. Her studies explore transdermal and intranasal drug administration, pharmacokinetics, and tissue engineering. She has contributed to the development of lab-on-a-chip models for drug testing, providing innovative solutions for pharmaceutical research. Her interdisciplinary approach combines pharmacology, biomedical engineering, and nanotechnology to improve drug formulation and delivery methods. She has authored numerous high-impact publications on skin permeability, microfluidic diffusion chambers, and age-related changes in drug absorption. Her research also includes in vitro and ex vivo studies on skin-on-a-chip platforms, contributing to advancements in personalized medicine. Dr. Erdő’s work has gained international recognition, shaping the future of drug development and targeted therapy solutions.

Awards and Honors

Dr. Erdő has been the recipient of numerous prestigious awards and fellowships throughout her career. She was a Max Planck Fellow from 2000 to 2003, a Charité Medical University Scholar in 2006, and a recipient of the LE STUDIUM Fellowship in 2022 under the Smart Loire Valley program in France. Her excellence in teaching and research has been recognized through multiple Teaching-Research Excellence Scholarships at Pázmány Péter Catholic University. She has also received publication fellowships for her outstanding contributions to scientific literature. Additionally, she plays a crucial role as a grant evaluator for the EU’s Horizon programs, the Austrian Science Fund, and other major research funding agencies. Her achievements highlight her significant impact on the global scientific community, reinforcing her reputation as a leading expert in pharmaceutical and biomedical research.

Conclusion

Dr. Franciska Vidáné Erdő is a highly suitable candidate for the Best Researcher Award due to her outstanding contributions to drug research, mentorship, and international collaborations. Her extensive publication record, leadership in scientific organizations, and impact on pharmacology and biomedical sciences make her a strong contender. Enhancing industry engagement and public science communication could further solidify her position as a top researcher.

Publications Top Noted

1. In Vitro Functional and Structural Evaluation of Low-Complexity Artificial Human Epidermis for 3D Tissue Engineering

  • Author: Erdő F., et al.
  • Year: 2025
  • Journal: Bioengineering
  • DOI: 10.3390/bioengineering12030230

2. Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

3. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations

4. Mathematical Modeling of Transdermal Delivery of Topical Drug Formulations in a Dynamic Microfluidic Diffusion Chamber in Health and Disease

5. Rodent Models of Dermatological Disorders

6. Models for Barrier Understanding in Health and Disease in Lab-on-a-Chips

7. Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

8. Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing

9. Editorial: Women in Drug Metabolism and Transport: 2021

10. Structural and Functional Analysis of Excised Skins and Human Reconstructed Epidermis with Confocal Raman Spectroscopy and in Microfluidic Diffusion Chambers

11. Novel Aspects of Raman Spectroscopy in Skin Research

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Experimental Dermatology
  • DOI: 10.1111/exd.14645

12. Characterization and Ex Vivo Evaluation of Excised Skin Samples as Substitutes for Human Dermal Barrier in Pharmaceutical and Dermatological Studies

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: Skin Research and Technology
  • DOI: 10.1111/srt.13165

13. Drug Delivery through the Psoriatic Epidermal Barrier—A “Skin-On-A-Chip” Permeability Study and Ex Vivo Optical Imaging

  • Author: Erdő F., et al.
  • Year: 2022
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms23084237

14. Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments

15. Age-Related Inflammatory Balance Shift, Nasal Barrier Function, and Cerebro-Morphological Status in Healthy and Diseased Rodents

 

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at University of Asia Pacific, Bangladesh

Dr. Shihab Uddin Ahmad (RPh, PhD) is an accomplished academic and researcher specializing in pharmacology, drug discovery, and molecular biology. Currently serving as an Assistant Professor and Coordinator of the Master of Pharmacy in Clinical Pharmacy and Pharmacology Program at the University of Asia Pacific, Bangladesh, he has made significant contributions to natural product pharmacology and functional medicine. With a postdoctoral background from Shanghai Jiao Tong University, he has actively engaged in cutting-edge research, particularly in stem cell therapy, metabolic diseases, and pharmaceutical innovations. His expertise spans experimental pharmacology, biotechnology, and advanced drug delivery systems, with a strong emphasis on translational research. A prolific author and patent holder, Dr. Ahmad’s work has been recognized through numerous publications in high-impact journals. His dedication to academic excellence and research innovation positions him as a leader in the field of pharmaceutical sciences.

Professional Profile

Education

Dr. Ahmad holds a Doctor of Philosophy (Ph.D.) in Pharmacology from Universiti Kebangsaan Malaysia, where he focused on wound healing properties of medicinal plants. He earned his Master of Science in Pharmaceutical Technology (M. Pharm. Tech.) and Bachelor of Pharmacy (B. Pharm.) from the University of Asia Pacific, Bangladesh, demonstrating an early interest in drug formulation, bioactive compounds, and molecular pharmacology. His academic journey has been driven by a passion for pharmacological research and drug discovery, equipping him with extensive biomedical expertise. Through his education, he developed proficiency in biochemical and molecular techniques, tissue recombination assays, and computational drug analysis. His multidisciplinary training in pharmacology, biotechnology, and clinical pharmacy has enabled him to bridge the gap between traditional medicine and modern pharmaceutical innovations, fostering impactful research in phytomedicine and metabolic disorders.

Professional Experience

Dr. Ahmad has a diverse professional background, spanning academia, industry, and postdoctoral research. Currently, he serves as the Coordinator and Assistant Professor at the University of Asia Pacific, Bangladesh, where he oversees research and academic programs in clinical pharmacy and pharmacology. Previously, he was a Postdoctoral Fellow at Renji Hospital, Shanghai Jiao Tong University, China, where he worked on cancer research and stem cell-based therapies. His industry experience includes serving as a Scientific Program Coordinator and Senior Executive at Ibn-Sina Natural Medicine Division, focusing on herbal drug development and product management. Additionally, he worked in the pharmaceutical production sector, gaining hands-on expertise in drug formulation, quality control, and regulatory affairs. His combined experience in research, industry, and education makes him a well-rounded professional with a strong impact in the field of drug discovery and molecular pharmacology.

Research Interests

Dr. Ahmad’s research interests focus on natural product pharmacology, drug delivery technology, and molecular biology, particularly in the development of phytomedicines and nutraceuticals. His work explores metabolic disorders, including obesity, diabetes, fatty liver disease, and postmenopausal hormonal imbalances such as PCOS and osteoporosis. He has also contributed to cancer pharmacology, investigating novel anticancer compounds and nanoparticle-based drug delivery systems. His expertise extends to neurodegenerative diseases and tissue regeneration, utilizing CRISPR technology, stem cell research, and bioinformatics to advance therapeutic innovations. By integrating experimental pharmacology with computational analysis, he aims to bridge the gap between traditional medicine and modern drug development. His ongoing research projects involve nanomedicine, polymeric drug delivery, and personalized medicine, reflecting a multidisciplinary approach to pharmaceutical sciences.

Awards and Honors

Dr. Ahmad has received numerous awards and recognitions for his contributions to pharmaceutical sciences and biomedical research. He is a patent holder for an innovative wound healing medicament, showcasing his ability to translate research into real-world applications. His research projects have been supported by prestigious grants from institutions such as UAP, Dhaka University, and international funding agencies. He has been an invited speaker at scientific conferences and has received accolades for his publications in high-impact journals. His work in drug discovery and therapeutic innovations has positioned him as a leading researcher in phytomedicine and clinical pharmacology. With an impressive track record of scientific achievements, mentorship, and academic leadership, Dr. Ahmad continues to make significant contributions to the advancement of pharmaceutical and biomedical sciences.

Conclusion

Dr. Shihab Uddin Ahmad is a strong candidate for the Best Researcher Award due to his extensive research contributions, leadership, and innovation in pharmacology and drug discovery. His combination of academic excellence, technical expertise, and mentorship makes him well-deserving of recognition. While enhancing international collaboration and increasing high-impact publications would further strengthen his profile, his overall achievements position him as a highly competitive contender for the award.

Publications Top Noted

  • Network Pharmacology, Molecular Docking and Experimental Validation on Potential Application of Diabetic Wound Healing of Cinnamomum zeylanicum Through Matrix Metalloproteinases-8 And 9 (MMP-8 And MMP-9)

    • Authors: Akter, S., Ahmad, S., Bhuiyan, M., Dewan, I., Reza, R., Morshed, N., Samdani, M., Reza, M., Kumer, A., Mohamed, I. N.
    • Year: 2025
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/DDDT.S489113

  • Metformin Hydrochloride Loaded Mucoadhesive Microspheres and Nanoparticles for Anti-Hyperglycemic and Anticancer Effects Using Factorial Experimental Design

    • Authors: Kotha, A. A., Ahmad, S. U., Dewan, I., Bhuiyan, M., Rahman, F. I., Mohamed, I. N., Reza, M. S.
    • Year: 2023
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/dddt.s432790

  • Antidiabetic Effect of Actinodaphne angustifolia and Profiling of Bioactive Metabolites using UPLC-QToF/ESI-MS Method

  • Improvement of lipid profile and hepatic oxidative stress in high-fat-diet-induced hyperlipidemic Swiss albino rats by Piper betle juice: evidences from in vivo and in silico studies

    • Authors: Jing, X., Sarker, M. R., Gifari, A. J., Maruf, R. A., Alam, S., Khan, F., Soma, M. A., Hossain, S., Ming, L. C., Ahmad, S. U.
    • Year: 2022
    • Journal: Cellular and Molecular Biology
    • DOI: 10.14715/cmb/2022.68.9.1

  • A Dose Optimization Study of Marantodes pumilum (Blume) Kuntze Extracts for Wound Healing Effect in Animal Model

  • Evaluation of Wound-Healing and Antioxidant Effects of Marantodes pumilum (Blume) Kuntze in an Excision Wound Model

  • The Pharmacological Potential of Oil Palm Phenolics (OPP) Individual Components

    • Author: Ahmad, S. U.
    • Year: 2019
    • Journal: International Journal of Medical Sciences
    • DOI: 10.7150/ijms.29934

  • Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction

  • Antioxidant and Anti-inflammatory Activities of Marantodes pumilum (Blume) Kuntze and Their Relationship with the Phytochemical Content

  • Labisia pumila improves wound healing process in ovariectomized rat model

  • Phyto-estrogenic effects of Marantodes pumilum (Blume) kuntze syn. Labisia pumila (Blume) Fern.-Vill. for the prevention and treatment of post-menopausal diseases

    • Authors: Ahmad, S. U., Azam, A., Shuid, A. N., Mohamed, I. N.
    • Year: 2017
    • Journal: Indian Journal of Traditional Knowledge
    • EID: 2-s2.0-85011866753